Concepts (89)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Huntington Disease | 4 | 2024 | 146 | 1.130 |
Why?
|
| RNA, Small Interfering | 5 | 2024 | 853 | 0.880 |
Why?
|
| Oligonucleotides | 3 | 2023 | 208 | 0.780 |
Why?
|
| Intra-Abdominal Fat | 6 | 2015 | 40 | 0.520 |
Why?
|
| Polymorphism, Single Nucleotide | 9 | 2015 | 462 | 0.460 |
Why?
|
| Huntingtin Protein | 3 | 2024 | 138 | 0.320 |
Why?
|
| Subcutaneous Fat | 3 | 2013 | 50 | 0.300 |
Why?
|
| Alleles | 3 | 2022 | 425 | 0.250 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2015 | 677 | 0.230 |
Why?
|
| Body Mass Index | 6 | 2015 | 891 | 0.220 |
Why?
|
| Organophosphorus Compounds | 1 | 2023 | 32 | 0.210 |
Why?
|
| Central Nervous System | 1 | 2024 | 191 | 0.200 |
Why?
|
| Organophosphonates | 1 | 2021 | 21 | 0.190 |
Why?
|
| Obesity | 4 | 2013 | 1189 | 0.190 |
Why?
|
| Cell Nucleus | 1 | 2024 | 603 | 0.180 |
Why?
|
| RNA, Messenger | 1 | 2024 | 1470 | 0.160 |
Why?
|
| DNA | 1 | 2023 | 793 | 0.150 |
Why?
|
| Gene Silencing | 3 | 2024 | 377 | 0.140 |
Why?
|
| Proteins | 2 | 2012 | 742 | 0.120 |
Why?
|
| Genetic Loci | 2 | 2012 | 106 | 0.120 |
Why?
|
| Genetic Association Studies | 2 | 2015 | 120 | 0.120 |
Why?
|
| Adiponectin | 1 | 2015 | 34 | 0.120 |
Why?
|
| Down-Regulation | 1 | 2015 | 306 | 0.110 |
Why?
|
| Acid Anhydride Hydrolases | 1 | 2013 | 6 | 0.110 |
Why?
|
| Metabolic Syndrome | 2 | 2015 | 150 | 0.100 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 1 | 2011 | 5 | 0.100 |
Why?
|
| 5'-Nucleotidase | 1 | 2011 | 3 | 0.100 |
Why?
|
| Insulin Resistance | 1 | 2015 | 403 | 0.100 |
Why?
|
| Humans | 13 | 2024 | 59308 | 0.090 |
Why?
|
| Mice | 4 | 2024 | 10256 | 0.090 |
Why?
|
| Genetic Variation | 1 | 2011 | 367 | 0.080 |
Why?
|
| Abnormalities, Multiple | 1 | 2009 | 52 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2012 | 675 | 0.080 |
Why?
|
| Genetic Testing | 1 | 2009 | 133 | 0.070 |
Why?
|
| Japan | 3 | 2012 | 60 | 0.070 |
Why?
|
| Gene Frequency | 3 | 2015 | 131 | 0.070 |
Why?
|
| Chromogranins | 1 | 2007 | 12 | 0.070 |
Why?
|
| Secretory Vesicles | 1 | 2007 | 23 | 0.070 |
Why?
|
| Neuropeptides | 1 | 2007 | 83 | 0.070 |
Why?
|
| Middle Aged | 9 | 2015 | 16233 | 0.070 |
Why?
|
| Animals | 4 | 2024 | 19612 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 2 | 2022 | 421 | 0.060 |
Why?
|
| Linkage Disequilibrium | 3 | 2009 | 49 | 0.060 |
Why?
|
| Apolipoproteins E | 1 | 2024 | 99 | 0.060 |
Why?
|
| Chemical Engineering | 1 | 2022 | 9 | 0.050 |
Why?
|
| Adiposity | 2 | 2015 | 81 | 0.050 |
Why?
|
| Male | 9 | 2015 | 27482 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2015 | 1454 | 0.050 |
Why?
|
| Waist-Hip Ratio | 2 | 2012 | 14 | 0.050 |
Why?
|
| Waist Circumference | 2 | 2013 | 55 | 0.050 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2023 | 250 | 0.050 |
Why?
|
| Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 2 | 2012 | 9 | 0.050 |
Why?
|
| Female | 9 | 2015 | 30805 | 0.050 |
Why?
|
| RNA Interference | 1 | 2024 | 591 | 0.050 |
Why?
|
| Adult | 6 | 2015 | 15731 | 0.040 |
Why?
|
| Receptor, Melanocortin, Type 4 | 2 | 2010 | 2 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 2023 | 314 | 0.040 |
Why?
|
| RNA | 1 | 2023 | 404 | 0.040 |
Why?
|
| Genotype | 2 | 2011 | 644 | 0.040 |
Why?
|
| Lung | 1 | 2023 | 825 | 0.040 |
Why?
|
| Alzheimer Disease | 1 | 2024 | 549 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2024 | 3189 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2024 | 2062 | 0.030 |
Why?
|
| Mutation | 1 | 2024 | 2427 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2015 | 199 | 0.030 |
Why?
|
| Dyslipidemias | 1 | 2012 | 34 | 0.030 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2012 | 14 | 0.030 |
Why?
|
| Metabolic Diseases | 1 | 2012 | 51 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2013 | 324 | 0.020 |
Why?
|
| Methionine Sulfoxide Reductases | 1 | 2010 | 2 | 0.020 |
Why?
|
| Transcription Factor AP-2 | 1 | 2010 | 12 | 0.020 |
Why?
|
| Aldose-Ketose Isomerases | 1 | 2009 | 5 | 0.020 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2009 | 36 | 0.020 |
Why?
|
| Group II Chaperonins | 1 | 2009 | 3 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2009 | 149 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2011 | 519 | 0.020 |
Why?
|
| Syndrome | 1 | 2009 | 173 | 0.020 |
Why?
|
| Haplotypes | 1 | 2009 | 117 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2009 | 403 | 0.020 |
Why?
|
| Radiography | 1 | 2010 | 505 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2009 | 485 | 0.020 |
Why?
|
| Appetite Regulation | 1 | 2007 | 9 | 0.020 |
Why?
|
| Hypertension | 1 | 2012 | 600 | 0.020 |
Why?
|
| Hypothalamus | 1 | 2007 | 120 | 0.020 |
Why?
|
| Aged | 2 | 2015 | 13288 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 1546 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2009 | 843 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2007 | 1059 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2009 | 1128 | 0.010 |
Why?
|